Metastatic Disease

Nathan I. Cherny, MD, has worked all around the world.

The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.

A program designed to better meet the needs of adolescents and young adults with cancer helped ensure more of them had access to guideline-concordant care, according to study findings.

A new electronic health record-based model accurately predicted risk for gastric cancer using demographic, behavioral and clinical data and may be leveraged to increase screening in at-risk populations.

Women diagnosed with advanced breast cancer appeared more likely than those with earlier-stage breast cancer to have pre-existing cardiovascular disease, according to results of a retrospective study.

Innovative dosing strategies are warranted to improve the well-being of individuals with metastatic breast cancer, according to a patient advocate-led study published in JCO Oncology Practice.

The American Society for Radiation Oncology has issued an updated clinical guideline that outlines best practices for addressing symptomatic bone metastases and improving quality of life for these patients.

In this video, Alexander Chehrazi-Raffle, MD, discusses the results of a study into the use of new precision medicine therapies in prostate cancer, presented at ASCO Annual Meeting.

Tiragolumab plus atezolizumab added to chemotherapy did not extend survival outcomes as first-line therapy of locally advanced unresectable or metastatic non-squamous non-small cell lung cancer, interim results from a randomized study showed.

Patients who received remote radiation oncology care from Memorial Sloan Kettering Cancer Center reported high levels of satisfaction, saved hundreds of dollars and had no additional safety risks compared with in-person visits.